Circulating desmosine as a biomarker of azithromycin treatment response: a post hoc analysis of the COLUMBUS randomised controlled trial

James D Chalmers (Lead / Corresponding author), Remco S Djamin, Marjolijn Schouten, Holly R Keir, Brendan Tan, Joachim G J V Aerts, Jeffrey T-J Huang, Menno van der Eerden

Research output: Contribution to journalArticle

95 Downloads (Pure)


Circulating desmosine is not reduced by treatment with azithromycin in COPD but elevated desmosine may identify a patient group with a greater treatment response

Original languageEnglish
Pages (from-to)1-4
Number of pages4
JournalERJ Open Research
Issue number4
Publication statusPublished - Oct 2018


Cite this